Abstract
The purposes of the present investigation were (i) to directly compare in man, indocyanine green (ICG) plasma concentrations analyzed by high performance liquid chromatography (HPLC) vs. spectrophotometry; (ii) to evaluate whether the pharmacokinetic parameters generated for ICG from a clinical study are assay-dependent; (iii) to examine whether the method of pharmacokinetic analysis affects the magnitude of any assay-related differences observed in ICG's pharmacokinetic parameters; and (iv) to evaluate whether assay methodology and/or method of pharmacokinetic analysis affect the conclusions derived from a clinical study employing ICG as a marker for hepatic blood flow (HBF).Plasma samples obtained from a clinical study designed to assess the effects of cimetidine and posture on HBFwere analyzed by spectrophotometry and HPLC. The spectrophotometric method overestimated ICG plasma concentrations when compared to HPLC. This finding is consistent with the observations of others suggesting the presence of a chemical impurity in the commercial ICG preparation. Data generated by the spectrophotometric method produced lower ICG clearance and HBFestimates and a longer ICG half-life regardless of the method'of pharmacokinetic analysis. The method of pharmacokinetic data analysis had no effect on any pharmacokinetic parameter. The experimental conclusions derived from the clinical study were not affected by either analytical methodology or method of data analysis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
I. J. Fox, L. G. S. Brooker, D. W. Heseltine, H. E. Essex, and E. H. Wood. A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation.Mayo Clin. Proc. 32:478–484 (1957).
I. J. Fox and E. H. Wood. Applications of dilution curves recorded from the right side of the heart or venous circulation with the aid of a new indicator dye.Mayo Clin. Proc. 32:541 (1957).
K. Winkler and N. Tygstrup. Determination of hepatic blood flow in man by Cardio-Green.Scand. J. Clin. Lab. Invest. 12:353–356 (1960).
J. Caesar, S. Shaldon, L. Chiandussi, L. Guevara, and S. Sherlock. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.Clin. Sci. 21:43–57 (1961).
C. M. Leevy, C. L. Mendenhall, W. Lesko, and M. M. Howard. Estimation of hepatic blood flow with indocyanine green.J. Clin. Invest. 41:1169–1179 (1962).
G. Paumgartner. The handling of indocyanine green by the liver. InSchweizerische Medizinische Wochenschrift Supplementum, Schwabe and Co., Basel, 1975, pp. 1–30.
P. L. Rappaport and J. J. Thiessen. High-pressure liquid Chromatographic analysis of indocyanine green.J. Pharm. Sci. 71:157–161 (1982).
R. Heintz, C. K. Svensson, K. Stoeckel, G. J. Powers, and D. Lalka. Indocyanine green: Pharmacokinetics in the rabbit and relevant studies of its stability and purity.J. Pharm. Sci. 75:398–402 (1986).
D. M. Grasela, M. L. Rocci Jr., H. H. Rotmensch, and P. H. Vlasses. Lack of effect of multiple doses of cimetidine on estimated hepatic blood flow.Biopharm. Drug Dispos. 8:63–72 (1987).
M. L. Rocci, Jr., and W. J. Jusko. LAGRAN program for area and moments in pharmacokinetic analysis.Comp. Prog. Biomed. 16:203–216 (1983).
L. Z. Benet and R. L. Galeazzi. Noncompartmental determination of the steady-state volume of distribution.J. Pharm. Sci. 68:1071–1074 (1979).
C. M. Metzler and D. L. Weiner.PCNONLIN User's Guide, Vol. A, Statistical Consultants, Inc., Lexington, KY, 1985.
K. Yamaoka, T. Nakagawa, and T. Uno. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.J. Pharmacokin. Biopharm. 6:165–175 (1978).
J. G. Wagner. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.J. Pharmacokin. Biopharm. 4:443–467 (1976).
K. J. Baker. Binding of sulfobromophthalein (BSP) sodium and indocyanine green (ICG) by plasmaα 1, lipoproteins.Proc. Soc. Exp. Biol. Med. 122:957–963 (1966).
F. Barbier and G. A. De Weerdt. Chromatography and i.r. spectrography of indocyanine green.Clin. Chim. Acta 10:549–554 (1964).
G. T. Tucker, J. P. Christie, N. D. S. Bax, and M. S. Leonard. Indocyanine green kinetics in man: A reappraisal, III World Conference on Clinical Pharmacology and Therapeutics, Stockholm, Sweden, 1986, p. 205.
T. K. Daneshmend, L. Jackson, and C. J. C. Roberts. Physiological and pharmacological variability in estimated hepatic blood flow in man.Brit. J. clin. Pharmacol. 11:491–496 (1981).
C. K. Svensson, D. J. Edwards, D. Lalka, P. M. Mauriello, and E. Middleton, Jr. Comparison of Chromatographic and spectrophotometric analysis of indocyanine green in plasma following administration of multiple doses to humans.J. Pharm. Sci,71:1305–1306 (1982).
K. H. Donn, J. R. Powell, J. F. Rogers, and J. R. Plachetka. Lack of effect of histamine H2-receptor antagonists on indocyanine green disposition measured by two methods,J. Clin. Pharmacol. 24:360–370 (1984).
J. Feely, G. R. Wilkinson, and A. J. J. Wood. Reduction of liver blood flow and propranolol metabolism by cimetidine.New Engl. J. Med. 304:692–695 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grasela, D.M., Rocci, M.L. & Vlasses, P.H. Experimental impact of assay-dependent differences in plasma indocyanine green concentration determinations. Journal of Pharmacokinetics and Biopharmaceutics 15, 601–613 (1987). https://doi.org/10.1007/BF01068415
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01068415